Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ADCY9 anticorps

ADCY9 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1944823
  • Antigène Voir toutes ADCY9 Anticorps
    ADCY9 (Adenylate Cyclase 9 (ADCY9))
    Reactivité
    • 31
    • 28
    • 18
    Humain
    Hôte
    • 46
    • 1
    Lapin
    Clonalité
    • 45
    • 1
    Polyclonal
    Conjugué
    • 15
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ADCY9 est non-conjugé
    Application
    • 40
    • 19
    • 13
    • 13
    • 9
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC)
    Isotype
    IgG1
  • Indications d'application
    WB: 1:1000. IHC: 1:50-1:100
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Stock
    4 °C,-20 °C
  • Tantisira, Small, Litonjua, Weiss, Liggett: "Molecular properties and pharmacogenetics of a polymorphism of adenylyl cyclase type 9 in asthma: interaction between beta-agonist and corticosteroid pathways." dans: Human molecular genetics, Vol. 14, Issue 12, pp. 1671-7, (2005) (PubMed).

    Small, Brown, Theiss, Seman, Weiss, Liggett: "An Ile to Met polymorphism in the catalytic domain of adenylyl cyclase type 9 confers reduced beta2-adrenergic receptor stimulation." dans: Pharmacogenetics, Vol. 13, Issue 9, pp. 535-41, (2003) (PubMed).

    Hacker, Tomlinson, Wayman, Sultana, Chan, Villacres, Disteche, Storm: "Cloning, chromosomal mapping, and regulatory properties of the human type 9 adenylyl cyclase (ADCY9)." dans: Genomics, Vol. 50, Issue 1, pp. 97-104, (1999) (PubMed).

  • Antigène
    ADCY9 (Adenylate Cyclase 9 (ADCY9))
    Autre désignation
    ADCY9 (ADCY9 Produits)
    Synonymes
    anticorps AC9, anticorps ACtp10, anticorps AW125421, anticorps D16Wsu65e, anticorps mKIAA0520, anticorps xlAC, anticorps ADCY9, anticorps adenylate cyclase 9, anticorps adenylate cyclase 9 L homeolog, anticorps ADCY9, anticorps Adcy9, anticorps adcy9.L, anticorps adcy9
    Sujet
    May play a fundamental role in situations where fine interplay between intracellular calcium and cAMP determines the cellular function. May be a physiologically relevant docking site for calcineurin (By similarity).
    Poids moléculaire
    150701 Da
    ID gène
    115
    UniProt
    O60503
    Pathways
    EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, cAMP Metabolic Process, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
Vous êtes ici:
Support technique